|

The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery

RECRUITINGPhase 4Sponsored by Konkuk University Medical Center
Actively Recruiting
PhasePhase 4
SponsorKonkuk University Medical Center
Started2023-12-01
Est. completion2025-08-15
Eligibility
Age4 Years – 7 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06035757

Summary

The present trial conducted to demonstrate the administration of sugammadex as reversal of neuromuscular blockade agent reduces the incidence of emergence agitation (EA) comparing to neostigmine

Eligibility

Age: 4 Years – 7 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients scheduled elective strabismus surgery aged 4-7 with American Society of Anesthesiologists (ASA) classification 1-3.

Exclusion Criteria:

* ASA classification 3 or more
* impaired liver function
* impaired kidney function
* myasthenia gravis or other neuromuscular disorders
* history of drug allergy
* cardiovascular disease or arrhythmia

Conditions4

CancerEmergence DeliriumPediatric ALLStrabismus

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.